Senior insider sale
Chief Operating Officer at X4 PHARMACEUTICALS, INC — senior position signals high conviction
$1.7K
2.64K shares
What this filing means
DIBIASE MARY plans to sell 2.64K shares of X4 PHARMACEUTICALS, INC valued at approximately $1.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/9/2024ACC: 0001973141-24-000445
Officer· Chief Operating Officer
Since Sep 2021
2.64K
Shares to sell
$1.7K
Approx. market value
2.64K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
RSU
NA
9/9/2024
2.64KTotal acquired2.64K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/9/2024 | RSU NA | 2.64K | — |
| Total | 2.64K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
2.64K
Market value
$1.7K
9/9/2024
Total
Units
2.64K
Value
$1.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
9/9/2024 | 2.64K | $1.7K | NASDAQ | Planned |
| Total | 2.64K | $1.7K | ||